Literature DB >> 26819208

Gankyrin regulates cell signaling network.

Xinxin Wang1, Bin Jiang1, Yanjie Zhang2.   

Abstract

Gankyrin is an oncoprotein that facilitates the degradation of two key tumor suppressors, namely, Rb and p53. Although Gankyrin overexpression was identified in different carcinomas eventually and associated with poor prognosis, its function and mechanism remain not well understood. Recently, the signal transduction mechanisms of Gankyrin have been explored, which may provide new drug targets in tumors overexpressing Gankyrin. In this review, we summarize the significant signal transduction pathways regulated by Gankyrin.

Entities:  

Keywords:  Biomarker; Cancer; Cell signaling pathway; Drug target; Gankyrin

Mesh:

Substances:

Year:  2016        PMID: 26819208     DOI: 10.1007/s13277-016-4854-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  67 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 2.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb.

Authors:  Junan Li; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2002-03-26       Impact factor: 3.162

4.  Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.

Authors:  Wen Sun; Jin Ding; Kun Wu; Bei-Fang Ning; Wen Wen; Han-Yong Sun; Tao Han; Lei Huang; Li-Wei Dong; Wen Yang; Xing Deng; Zhong Li; Meng-Chao Wu; Gen-Sheng Feng; Wei-Fen Xie; Hong-Yang Wang
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

5.  Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.

Authors:  Kian-Huat Lim; Christopher M Counter
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

Review 6.  Inflammasomes in liver diseases.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

Review 7.  Gankyrin: an intriguing name for a novel regulator of p53 and RB.

Authors:  Guillermina Lozano; Gerard P Zambetti
Journal:  Cancer Cell       Date:  2005-07       Impact factor: 31.743

8.  The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.

Authors:  Ki Hyun Kim; Hye Jin Lim; Yeon Ju Kim; Seung Won Kim; Young Sun Kim; Chunjie Tian; Keehyun Park; Tae Jun Park; Yun-Hoon Choung
Journal:  Acta Otolaryngol       Date:  2014-01-27       Impact factor: 1.494

9.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

10.  Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.

Authors:  Cristian M Ortiz; Tetsuo Ito; Eiji Tanaka; Shigeru Tsunoda; Satoshi Nagayama; Yoshiharu Sakai; Hiroaki Higashitsuji; Jun Fujita; Yutaka Shimada
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

View more
  7 in total

Review 1.  Gankyrin as a potential therapeutic target for cancer.

Authors:  Chongchong Wang; Li Cheng
Journal:  Invest New Drugs       Date:  2017-05-19       Impact factor: 3.850

2.  LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells.

Authors:  Yuan Liu; Lamei Chen; Huabing Yuan; Shenghong Guo; Gang Wu
Journal:  Onco Targets Ther       Date:  2020-02-05       Impact factor: 4.147

3.  Role of a 19S Proteasome Subunit- PSMD10Gankyrin in Neurogenesis of Human Neural Progenitor Cells.

Authors:  Indrajit Sahu; Padma Nanaware; Minal Mane; Saim Wasi Mulla; Soumen Roy; Prasanna Venkatraman
Journal:  Int J Stem Cells       Date:  2019-11-30       Impact factor: 2.500

Review 4.  Biological effects and regulation of IGFBP5 in breast cancer.

Authors:  Jürgen Dittmer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

5.  Distinct ankyrin repeat subdomains control VAPYRIN locations and intracellular accommodation functions during arbuscular mycorrhizal symbiosis.

Authors:  Penelope L Lindsay; Sergey Ivanov; Nathan Pumplin; Xinchun Zhang; Maria J Harrison
Journal:  Nat Commun       Date:  2022-09-05       Impact factor: 17.694

6.  Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block.

Authors:  Michael Pimienta; Ekihiro Seki
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-07-07

7.  LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients.

Authors:  Xu Guo; Haozhe Piao; Yixue Xue; Yunhui Liu; Hongyu Zhao
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.